^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    spevatamig (PT886)

    i
    Associations
    News
    Trials
    Company:
    Phanes Therap
    Drug class:
    CD47 inhibitor, CLDN18.2 inhibitor
    Related drugs:
    Associations
    News
    Trials